Equities

Avalo Therapeutics Inc

Avalo Therapeutics Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)9.59
  • Today's Change-0.05 / -0.52%
  • Shares traded64.46k
  • 1 Year change-98.57%
  • Beta1.0981
Data delayed at least 15 minutes, as of May 17 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
AVTX:NAQ since
announced
Transaction
value
AlmataBio IncDeal completed27 Mar 202427 Mar 2024Deal completed107.58%20.92m
Data delayed at least 15 minutes, as of May 17 2024 21:00 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Notable Labs Ltd310.00k-11.26m9.20m16.00--0.6086--29.67-3.08-3.080.09391.680.0126----19,375.00-45.79-52.02-56.70-62.0936.4560.19-3,633.55-3,636.93----0.0221---52.89-11.9365.13---50.69--
Ayala Pharmaceuticals Inc13.00k-48.07m9.38m20.00------721.49-7.46-7.460.0022-2.06------650.00--------0.00---369,784.60-----2.31----------------
Molecular Templates Inc31.76m-18.40m9.55m62.00--1.33--0.3006-4.36-4.365.981.090.6014--19.55512,306.40-34.83-51.78-54.80-73.14-----57.92-228.33---52.110.00--190.1033.9691.24---48.87--
Weed Inc0.00-31.55k9.63m2.00--37.73337.48---0.0002-0.00020.000.00210.00----0.00-2.49-385.93-14.84-822.37-----------16.980.3488------97.93---59.13--
Mira Pharmaceuticals Inc0.00-12.36m9.68m3.00--3.07-----0.8276-0.82760.000.21360.00----0.00-587.64---1,721.90-------------2.630.00-------69.77------
Avalo Therapeutics Inc1.45m-142.88m9.92m19.00------6.84-318.69-318.693.02-97.750.0181--3.2576,315.79-178.64-99.64---154.4254.9084.69-9,853.73-613.58---0.2415-----89.34-22.8324.28---22.48--
Chromocell Therapeutics Corp0.00-7.38m10.09m4.00---------1.28-1.280.00-1.120.00----0.00-9,746.19-----------------13.23---------200.20------
BioNexus Gene Lab Corp9.77m-2.63m10.14m30.00--1.05--1.04-0.1389-0.13890.68730.54660.97037.985.33---26.11-3.83-31.86-5.0213.6114.55-26.91-3.044.24-186.190.00---10.60115.07-638.56--30.40--
Medical Marijuana Inc-100.00bn-100.00bn10.26m----0.1104----------0.019-----------22.66---23.11--70.58---145.521.79--0.0479--26.3039.07141.59---0.016--
Vaxxinity Inc0.00-56.94m10.27m57.00--0.7656-----0.4499-0.44990.000.10580.00----0.00-75.56---111.46--------------0.5308------24.31------
Oragenics Inc37.65k-20.66m10.44m5.00--4.56--277.29-8.69-8.690.01671.030.0038----7,530.00-209.44-97.60-252.98-106.24-----54,862.55-36,169.75----0.0898---71.37---44.56--51.64--
Galera Therapeutics Inc0.00-45.75m10.66m7.00---------0.9971-0.99710.00-2.480.00----0.00-115.30-83.69-142.79-97.54-----------6.499.23------5.05---29.84--
Data as of May 17 2024. Currency figures normalised to Avalo Therapeutics Inc's reporting currency: US Dollar USD

Institutional shareholders

15.44%Per cent of shares held by top holders
HolderShares% Held
Deep Track Capital LPas of 27 Mar 2024114.78k14.32%
Natixis Investment Managers International SAas of 31 Dec 20234.60k0.57%
BlackRock Fund Advisorsas of 31 Mar 20242.12k0.26%
Tower Research Capital LLCas of 31 Dec 20231.77k0.22%
Banque Cantonale Vaudoise (Investment Management)as of 31 Mar 2024338.000.04%
RBC Dominion Securities, Inc.as of 31 Dec 2023138.000.02%
Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Dec 202341.000.01%
BlackRock Investment Management LLCas of 31 Mar 20248.000.00%
Wells Fargo Bank, NA (Private Banking)as of 31 Mar 20246.000.00%
BNP Paribas Financial Marketsas of 31 Mar 20244.000.00%
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.